Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60616


The purpose of this study is to evaluate the safety of MRI-guided laser-induced thermal therapy of biopsy confirmed low-risk prostate cancer.


Inclusion Criteria: - Male, 45 years of age or older - Diagnosis of prostate adenocarcinoma - Clinical stage T1c or T2a - Gleason score of 7 or less - A minimum of 12 biopsy cores sampled during diagnostic biopsy - Three or fewer biopsy cores with prostate cancer - No single biopsy core with greater than 50% of tumor involvement - A radiographically visible prostate lesion on MRI with concordance to biopsy sextant - A documented Karnofsky performance status of at least 70 - Estimated survival of 20 years or greater, as determined by treating physician - Ability to give informed consent Exclusion Criteria: - Previous surgery, radiation, or androgen deprivation therapy for prostate cancer - Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI - History of previous pelvic radiation - Severe lower urinary tract symptoms as measured by an International Prostate Symptom Score (IPSS) of 20 or greater. (See Appendix A) - History of other primary non-skin malignancy within previous three years



Primary Contact:

Principal Investigator
Scott E Eggener, MD
University of Chicago

Backup Contact:


Location Contact:

Chicago, Illinois 60616
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.